TATA Health International Holdings Limited (1255.HK) Stock Overview
Explore TATA Health International Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
TATA Health International Holdings Limited (1255.HK)
Key Financials
Key Financials
Market Cap
533M
P/E Ratio
40.00
EPS (TTM)
$-0.09
ROE
-0.26%
1255.HK Stock Analysis & Investment Overview (HKSE)
Our AI-powered analysis of TATA Health International Holdings Limited (HKSE: 1255.HK) gives investors deep insight into how the stock performs on the HKSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, TATA Health International Holdings Limited's HKSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 1255.HK on the HKSE shows an RSI of 39.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.39 for the HKSE listing.
Key metrics behind TATA Health International Holdings Limited's HKSE-traded stock include a P/E ratio of 40.00 and a market capitalization of 533M. Combined with our AI analysis, these give both institutional and retail investors a clear view of 1255.HK on the HKSE.